🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was awarded for transformative discoveries that illuminate how the immune system targets harmful pathogens while protecting the healthy tissues.

A trio of esteemed scientists—from Japan Prof. Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—received this honor.

Their research uncovered unique "security guards" within the immune system that eliminate malfunctioning defense cells that could harming the organism.

These discoveries are now enabling new therapies for immune disorders and malignancies.

These laureates will divide a monetary award worth 11 million SEK.

Decisive Findings

"Their research has been essential for comprehending how the immune system operates and why we don't all suffer from severe autoimmune diseases," commented the chair of the Nobel Committee.

This trio's studies explain a core question: How does the defense system protect us from countless invaders while leaving our healthy cells intact?

The body's protection system employs immune cells that scan for indicators of disease, even pathogens and germs it has never encountered.

Such cells utilize detectors—known as recognition units—that are generated randomly in countless combinations.

This provides the defense network the ability to fight a broad range of invaders, but the unpredictability of the mechanism unavoidably produces immune cells that can target the host.

Security Guards of the Immune System

Scientists earlier understood that a portion of these harmful white blood cells were eliminated in the immune organ—the site where immune cells mature.

The latest award honors the identification of T-reg cells—described as the immune system's "security guards"—which patrol the system to disarm any immune cells that assault the body's own tissues.

It is known that this mechanism fails in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel stated, "These findings have established a novel area of research and accelerated the development of new treatments, for instance for cancer and autoimmune diseases."

Regarding malignancies, regulatory T-cells prevent the body from fighting the growth, so research are aimed at lowering their quantity.

For autoimmune diseases, trials are exploring boosting regulatory T-cells so the body is no longer under attack. A similar method could also be useful in reducing the chances of transplanted organ failure.

Innovative Studies

Prof Shimon Sakaguchi, from Osaka University, conducted tests on mice that had their thymus extracted, causing autoimmune disease.

He demonstrated that introducing defense cells from healthy mice could stop the illness—implying there was a mechanism for blocking immune cells from attacking the body.

Mary Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, now at a biotech firm in San Francisco, were studying an genetic immune disorder in mice and people that resulted in the discovery of a gene critical for the way T-regs operate.

"Their pioneering work has uncovered how the immune system is kept in check by T-reg cells, stopping it from accidentally targeting the healthy cells," said a prominent physiology specialist.

"This work is a remarkable illustration of how basic biological study can have far-reaching consequences for public health."